Literature DB >> 1644658

Basic design considerations for clinical trials in oncology.

S Piantadosi1, N Saijo, T Tamura.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1644658      PMCID： PMC5918883          DOI： 10.1111/j.1349-7006.1992.tb00124.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN： 0910-5050


× No keyword cloud information.
  61 in total

1.  A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer.

Authors:  T Shinkai; K Eguchi; Y Sasaki; T Tamura; Y Ohe; A Kojima; F Oshita; N Saijo
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

2.  Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1988-01-28       Impact factor: 91.245

3.  Use of unequal allocation in survival trials.

Authors:  R Sposto; M D Krailo
Journal:  Stat Med       Date:  1987-03       Impact factor: 2.373

4.  Cross-over trials, carry-over effects and the art of self-delusion.

Authors:  S J Senn
Journal:  Stat Med       Date:  1988-10       Impact factor: 2.373

5.  Non-randomized controls in cancer clinical trials.

Authors:  E A Gehan; E J Freireich
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

6.  Policies for interim analysis and interim reporting of results.

Authors:  J R O'Fallon
Journal:  Cancer Treat Rep       Date:  1985-10

7.  The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians.

Authors:  M J Stampfer; J E Buring; W Willett; B Rosner; K Eberlein; C H Hennekens
Journal:  Stat Med       Date:  1985 Apr-Jun       Impact factor: 2.373

8.  Problems in controlled trials--a critical response.

Authors:  D W Vere
Journal:  J Med Ethics       Date:  1983-06       Impact factor: 2.903

9.  Negative phase II study of 5-fluorouracil with high-dose leucovorin in non-small cell lung cancer.

Authors:  Y Ohe; T Shinkai; K Eguchi; Y Sasaki; T Tamura; K Nakagawa; A Kojima; K Yamada; F Oshita; T Miya
Journal:  Jpn J Clin Oncol       Date:  1990-12       Impact factor: 3.019

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640
View more
  3 in total

Review 1.  Methodologies for evaluating HIV prevention intervention (populations and epidemiologic settings).

Authors:  Ronald H Gray
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

Review 2.  Highlights for ESMO 40: celebration review for lifetime achievement awards.

Authors:  Nagahiro Saijo
Journal:  ESMO Open       Date:  2016-02-17

3.  Guidelines for analysis and reporting of clinical trials in oncology.

Authors:  S Piantadosi; N Saijo; T Tamura
Journal:  Jpn J Cancer Res       Date:  1993-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.